Pheno Therapeutics

Progentos Therapeutics

The company develops small-molecule drugs to regenerate myelin for the treatment of patients with multiple sclerosis.

Convelo Therapeutics

This biotechnology company develops medicines to regenerate nerve cell myelin for patients with neurological disorders, including multiple sclerosis and paediatric leukodystrophies.

Accure Therapeutics

This biopharmaceutical company develops central nervous system medicines to treat patients with conditions such as multiple sclerosis, Parkinson's disease, epilepsy and optic neuritis.

Minoryx Therapeutic

This biotech company develops therapies for orphan central nervous system diseases, such as X-linked adrenoleukodystrophy, for patients with high unmet medical needs.

MindImmune Therapeutics

This company develops monoclonal antibody therapeutics to treat neurodegenerative diseases and neuroinflammation for patients with central nervous system disorders.

NeurOdys Therapeutics

This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.

Autobahn Therapeutics

This company develops brain-penetrating small molecule therapies for patients with neuropsychiatric and neuroimmunologic disorders, including depression and multiple sclerosis.

Cadenza Bio

This biotechnology company develops small-molecule drugs to treat demyelinating and inflammatory diseases, such as multiple sclerosis and endometriosis, for patients and healthcare providers.